As COVID-19 continues to evolve, the Food and Drug Administration is proposing plans to roll out an updated vaccine every year going forward.
The agency is suggesting experts select a specific strain of the virus each spring and introduce the vaccine to the market by September — similar to annual flu shots.
The FDA will also recommend that most people get just a single yearly jab, though older adults, immunocompromised people, and very young children may still need two doses.
The agency will request input from a panel of vaccine experts on Thursday, but the plan aligns with the recommendations the Biden administration announced last year. In September, Rochelle Walensky, the director of the Centers for Disease Control and Prevention, said that annual shots could save thousands of lives.
"Modeling projections show that an uptake of updated COVID-19 vaccine doses similar to an annual flu vaccine coverage early this fall could prevent as many as 100,000 hospitalizations, 9,000 deaths, and save billions of dollars in direct medical costs," she said.
However, reception to booster shots has been cool. Though four out of five Americans have received at least one dose, only 16 percent of those eligible have gotten the latest booster, which was released in August.
So far, there have been more than 100 million confirmed cases and greater than one million COVID-19-related deaths, according to Johns Hopkins University.
On Monday, football fans were stunned when Buffalo Bills safety Damar Hamlin collapsed and suffered cardiac arrest. Cheddar News explains the condition and the steps to take if you witness an incident.
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
Join Cheddar News as we break down the top headlines this morning including updates on the Jan. 6 hears, the PGA suspension of 17 of the world's best golfers, and NASA's plans to study UFOs.
Rick Pauls, President & CEO OF DiaMedica Therapeutics, joins Cheddar Innovates to discuss a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients.
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
